Cala Health recently launched its kIQ system — which it calls the first noninvasive wearable device cleared by the FDA to temporarily relieve tremors in people with essential tremor and Parkinson’s disease.
At HLTH, leaders of the Michael J. Fox Foundation shared the importance of including patient voices in research, and how engaging patients has led to important findings in Parkinson’s research.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Unlearn.AI, a comapny using machine learning to generate control patients for clinical trials, raised a $12 million series A round. Several other startups shared funding news this week.
Numerous companies with remote-monitoring and telehealth services closed funding rounds this week. Tyto Care, which gives users the tools to conduct an at-home medical exam with their doctor, raised $50 million. On the biotech side, Aspen Neuroscience, which is developing a new treatment for Parkinson's disease, raised $70 million.
Insightec, a company making an ultrasound device that can be used to treat essential tremor, raised $150 million. The company now has a post-money valuation of $1.3 billion.
Bad news has piled up at Axovant, including the poor showing of its Parkinsons/Lewy body drug, and now the CEO David Hung is out after a mere 10 months on the job.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Here's a look at some of the most popular stories from this past week in healthcare.
Neuro Vigor, a startup based in Indiana, has a new theory for what causes multiple sclerosis — and has found a generic hypertension drug that could potentially be repurposed to treat an array of neurodegenerative diseases.
While we all marveled over Medtronic’s latest DBS system, GE-held Insightec (based in Israel) has published results from a pilot study in the NEJM that may validate the Exablate Neuro, a device that combines focused ultrasound surgery with continuous MRI via a “helmet” transducer that shoots out ultrasound elements, stopping the tremors. It’s “noninvasive, incisionless […]
It’s no secret that most seniors today prefer to “age in place” — and healthcare innovators hear that loud and clear. But despite patients’ preferences, chronic illnesses that cause many seniors to require care that’s difficult to provide at home aren’t going away any time soon. Nursing homes and assisted-living facilities face unique challenges in […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Ossianix, an early stage biopharmaceutical startup that utilizes shark antibodies as a model for drugs to treat central nervous system disorders, has received a strategic investment from Danish pharmaceutical company H Lundbeck. The investment amount was not disclosed, but Dr. Frank Walsh, cofounder and CEO of Ossianix, said it would be enough to fund the […]